{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:38:29Z","timestamp":1791999509090,"version":"4.4.0"},"reference-count":31,"publisher":"Hindawi Limited","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2975,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2007.01458.x","type":"journal-article","created":{"date-parts":[[2007,7,11]],"date-time":"2007-07-11T05:32:55Z","timestamp":1184131975000},"page":"1256-1269","source":"Crossref","is-referenced-by-count":26,"title":["Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, mu"],"prefix":"10.1155","volume":"61","author":[{"given":"G.","family":"Sandrini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cerbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Del Bene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Genco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Grazioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Martelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pinessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sarchielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tamburro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Uslenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zanchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2007,7,10]]},"reference":[{"issue":"Suppl. 1","key":"10.1111\/j.1742-1241.2007.01458.x-BIB1|cit1","first-page":"1S","article-title":"The holistic hypothesis of migraine","volume":"12","author":"Sicuteri","year":"1997","journal-title":"Ann Ital Med Int"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-2999(94)90522-3","article-title":"Central mechanism of indomethacin analgesia","volume":"263","author":"Hu","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0014-2999(02)02307-5","article-title":"The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels","volume":"452","author":"Akerman","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0301-0082(98)00071-9","article-title":"The effects on the central nervous system of nitroglycerin - Putative mechanisms and mediators","volume":"57","author":"Tassorelli","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0304-3959(90)91111-U","article-title":"Central effect of the non-steroid anti-inflammatory agents, indomethacin, ibuprofen, and diclofenac, determined in C fibre-evoked activity in single neurones of the rat thalamus","volume":"41","author":"Jurna","year":"1990","journal-title":"Pain"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/ard.51.3.391","article-title":"Analgesic effect of indomethacin shown using the nociceptive flexion reflex in humans","volume":"51","author":"Guieu","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jpain.2004.06.008","article-title":"Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine","volume":"5","author":"Ghelardini","year":"2004","journal-title":"J Pain"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1526-4610.2005.05153.x","article-title":"Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1\/COX2 inhibitors","volume":"45","author":"Jakubowski","year":"2005","journal-title":"Headache"},{"issue":"Suppl. 1","key":"10.1111\/j.1742-1241.2007.01458.x-BIB9|cit9","first-page":"1","article-title":"The international classification of headache disorders - 2nd edition","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/cpt196563336","article-title":"Termination of migraine headache by a new anti-inflammatory vasoconstrictor agent","volume":"6","author":"Sicuteri","year":"1965","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB11|cit11","first-page":"397","article-title":"Migraine and non-steroidal anti-inflammatory agents","volume":"40","author":"Pradalier","year":"1992","journal-title":"Pathol Biol"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11916-004-0036-6","article-title":"Indomethacin-responsive headache syndromes","volume":"8","author":"Dodick","year":"2004","journal-title":"Curr Pain Headache Rep"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.phrs.2004.02.005","article-title":"Prochlorperazine induces central antinociception mediated by the muscarinic system","volume":"50","author":"Ghelardini","year":"2004","journal-title":"Pharmacol Res"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB14|cit14","unstructured":"US Headache Consortium Evidence-based Guidelines for Migraine Headache in the Primary Care Setting: Pharmacological Management of Acute Attacks http:\/\/www.aan.com\/"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1046\/j.1526-4610.2002.02210.x","article-title":"Efficacy and tolerability of prochlorperazine buccal tablets in treatment of acute migraine","volume":"42","author":"Sharma","year":"2002","journal-title":"Headache"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/PL00005094","article-title":"Caffeine induces central cholinergic analgesia","volume":"356","author":"Ghelardini","year":"1997","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.1984.03340370043028","article-title":"Caffeine as an analgesic adjuvant","volume":"251","author":"Laska","year":"1984","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2165\/00002018-200124150-00004","article-title":"A benefit-risk assessment of caffeine as an analgesic adjuvant","volume":"24","author":"Zhang","year":"2001","journal-title":"Drug Saf"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1043-6618(02)00126-3","article-title":"Indomethacin, caffeine and prochlorperazine alone and combined revert hyperalgesia in \u2018\u2018in vivo\u2019\u2019 models of migraine","volume":"46","author":"Galeotti","year":"2002","journal-title":"Pharmacol Res"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.10786","article-title":"Defeating migraine pain with triptans: a race against the development of cutaneous allodynia","volume":"55","author":"Burstein","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1526-4610.2003.03161.x","article-title":"Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in the acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial","volume":"43","author":"Di Monda","year":"2003","journal-title":"Headache"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1468-1331.2005.01056.x","article-title":"Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine in the treatment of episodic tension-type headache: a double-blind, randomized, nimesulide-controlled, parallel group, multicentre trial","volume":"12","author":"Cerbo","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1468-2982.2002.00404.x","article-title":"Triptans (serotonin, 5-HT1B\/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials","volume":"22","author":"Ferrari","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1468-2982.2000.00117.x","article-title":"Guidelines for controlled trials of drugs in migraine: second edition","volume":"20","author":"International Headache Society Clinical Trials Subcommittee","year":"2000","journal-title":"Cephalalgia"},{"issue":"Suppl. 7","key":"10.1111\/j.1742-1241.2007.01458.x-BIB25|cit25","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","volume":"8","author":"Headache Classification Committee of the International Headache Society","year":"1988","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB26|cit26","unstructured":"Note for Guidance on Clinical Investigation of Medicinal Products for the Treatment of Migraine 2003"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-2982.1999.019002107.x","article-title":"Reliability of the migraine disability assessment score in a population-based sample of headache sufferers","volume":"19","author":"Stewart","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archneur.58.6.944","article-title":"Oral almotriptan vs oral sumatriptan in the abortive treatment of migraine. A double-blind, randomized, parallel-group, optimum-dose comparison","volume":"58","author":"Spierings","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1526-4610.1998.3810737.x","article-title":"Crossover comparison of rizatriptan 5\u2003mg and 10\u2003mg versus sumatriptan 25\u2003mg and 50\u2003mg in migraine","volume":"38","author":"Goldstein","year":"1998","journal-title":"Headache"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1468-2982.2004.00939.x","article-title":"Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain - results of a model-based meta-analysis that accounts for encapsulation","volume":"25","author":"Mandema","year":"2005","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1742-1241.2007.01458.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2165\/00003495-200060060-00003","article-title":"Triptans in migraine. A comparative review of pharmacology, pharmacokinetics and efficacy","volume":"60","author":"Tfelt-Hansen","year":"2000","journal-title":"Drugs"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2007.01458.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2007.01458.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:05:42Z","timestamp":1643349942000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2007.01458.x"}},"subtitle":["Indoprocaf vs. sumatriptan in the acute treatment of migraine"],"short-title":[],"issued":{"date-parts":[[2007,7,10]]},"references-count":31,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2007.01458.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7,10]]}}}